Trauma News and Research

RSS

NJISA experts to discuss science, impact and current state of Alzheimer's disease in America

The New Jersey Institute for Successful Aging (NJISA) at the UMDNJ-School of Osteopathic Medicine, one of the country's leading providers of geriatric care, research and education, is making experts available who can discuss the science, impact and current state of Alzheimer's disease in America.

20 Nov 2010

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire all of the hemophilia-related assets of a privately-held biopharmaceutical company, Archemix, and entered into an exclusive license agreement for certain related intellectual property assets.

From Baxter International Inc. 19 Nov 2010

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.

19 Nov 2010

Experts formulate research related to psychological adjustment and traumatic brain injury

Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).

19 Nov 2010

New book for parents of premature infants

Years after the homecoming, parents of premature infants frequently report difficulty explaining the concept to their children, and are unprepared to handle their strong reactions.

19 Nov 2010

Advanced Life Sciences submits application to FDA for ALS-886 to treat ARDS

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).

19 Nov 2010

FDA approves IDE application for Home Hemodialysis system

Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application for a Home Hemodialysis (HD) system in development through a collaboration between DEKA Research and Development Corp., HHD LLC, and Baxter.

From Baxter International Inc. 19 Nov 2010

Viking Systems completes CE certification process for new 3DHD Vision System

Viking Systems, Inc. announced today that it has completed the CE certification process related to its new 3DHD Vision System. The Company also commented on its first day of exhibiting at the Medica Trade Show 2010 (Medica) in Dusseldorf, Germany.

18 Nov 2010

Spleen cells may do more harm than good at site of spinal cord injury

The spleen, an organ that helps the body fight infections, might also be a source of the cells that end up doing more harm than good at the site of a spinal cord injury, new research suggests.

18 Nov 2010

Special glasses to spot people at risk for PTSD

Around 30 percent of people surviving a traumatic event, such as a serious car crash, will go on to develop Post Traumatic Stress Disorder (PTSD). Doctors don't know who is susceptible and treating people who don't have PTSD can make things worse. However, new research by psychologist Dr Peter Naish, of the Open University, and his colleague Dr Ksenja da Silva, may help.

18 Nov 2010

Researchers discover NG2+ cells may impact ALS disease progression

By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease.

18 Nov 2010

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.

17 Nov 2010

Viking's new 3DHD Vision System recognized with 'Best of What's New 2010' award

Viking Systems, Inc. announced today that its recently released 3DHD Vision System has been named a "Best of What's New 2010" award winner in the Health category by Popular Science magazine. The award recipients were included in the December issue of the magazine.

17 Nov 2010

U-M researcher awarded $600,000 grant for study of progesterone in treatment of children with TBI

A University of Michigan researcher has received a two-year, $600,000 grant to plan a randomized controlled study of progesterone for the treatment of traumatic brain injury in children.

17 Nov 2010

John Muir Health opens The Hofmann Family Patient Care Tower

Today, John Muir Health opened the doors of The Hofmann Family Patient Care Tower at John Muir Medical Center, Concord, which includes 120 new private rooms (61 open with 59 shelled for future use), a new Cardiovascular Institute and a new Emergency Department. The 172,000 square foot facility, which took three years and $212 million to complete, also features state-of-the-art technology and a patient-focused, healing environment.

17 Nov 2010

Medtronic acquires Osteotech

Moving to expand its Biologics product offerings, Medtronic, Inc., announced today it has completed the acquisition of Osteotech, following payment of $6.50 per share in cash for each share of Osteotech stock, with a total transaction value of approximately $123 million.

16 Nov 2010

Health researchers to address mental health concerns at world conference

More than 500 mental health researchers, practitioners, and advocates representing over 40 countries will gather for the Sixth World Conference on the Promotion of Mental Health and Prevention of Mental and Behavioral Disorders, November 17–19, 2010, at the Omni Shoreham Hotel in Washington, D.C. With the theme Addressing Imbalances: Promoting Equity in Mental Health, the conference will focus on inequalities in care, research, and practice in ways that protect the most vulnerable.

16 Nov 2010

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

Education for women is the most important factor for positively influencing the health of women and children, Indian President Pratibha Patil said on Saturday at a meeting in New Delhi of The Partnership for Maternal, Newborn & Child Health (PMNCH), IANS/Sify News reports. "Education is a powerful driver of health. The relationship between poverty, lack of education and limited access to health services, is well recognised," Patil said at the start of the two-day conference (11/13).

16 Nov 2010

Research suggests targeting spleen may promote healing of spinal cord injury

The spleen, an organ that helps the body fight infections, might also be a source of the cells that end up doing more harm than good at the site of a spinal cord injury, new research suggests.

16 Nov 2010

Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association

Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).

16 Nov 2010

Trauma News and Research

NJISA experts to discuss science, impact and current state of Alzheimer's disease in America

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Experts formulate research related to psychological adjustment and traumatic brain injury

New book for parents of premature infants

Advanced Life Sciences submits application to FDA for ALS-886 to treat ARDS

FDA approves IDE application for Home Hemodialysis system

Viking Systems completes CE certification process for new 3DHD Vision System

Spleen cells may do more harm than good at site of spinal cord injury

Special glasses to spot people at risk for PTSD

Researchers discover NG2+ cells may impact ALS disease progression

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Viking's new 3DHD Vision System recognized with 'Best of What's New 2010' award

U-M researcher awarded $600,000 grant for study of progesterone in treatment of children with TBI

John Muir Health opens The Hofmann Family Patient Care Tower

Medtronic acquires Osteotech

Health researchers to address mental health concerns at world conference

Leaders speak at Partnership for Maternal, Newborn and Child Health conference

Research suggests targeting spleen may promote healing of spinal cord injury

Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News